HPM Partners »

Gt Biopharma shares owned by HPM Partners

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $12k 15k 0.79

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Procter & Gamble Company (PG)
Ishares Tr Core Us Aggbd Et (AGG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Gt Biopharma

Scientech Research
SeaCrest Wealth Management
Citadel Advisors
Jane Street
Integrated Wealth Concepts
Geode Capital Management
Coston, McIsaac & Partners
Caitlin John
Wells Fargo & Company
HPM Partners
Am Investment Strategies
Verdence Capital Advisors
Two Sigma Securities
Prospera Financial Services
Hrt Financial

View all funds holding Gt Biopharma